PapersPMID:30151373
Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 8 weeks
- Dose studied, every finding
- coenzyme Q10 200 mg/day for 8 weeks
- Population, every finding
- adults with impaired glucose tolerance (prediabetes)
No finding here moved its endpoint.
What did not
How to read these marks →“Additionally, the groups did not differ significantly in terms of the fasting blood glucose, insulin, and HbA1c concentrations.”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- adults aged 20-65 years with impaired glucose tolerance (prediabetes)
- Participants
- 80
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 8